Sayumi Yamazoe

Company: Bristol Myers Squibb

Job title: Associate Director

Seminars:

Considering a Non-Oncology Target as a Route for Tumor Cell Killing With a Reduced Risk of Target Resistance 3:00 pm

Overcoming the growing concerns of ADC resistance through selecting less-specific targets such as the fibroblast Exploiting the fibroblast to engulf the ADC payload to then deliver the therapeutic to the neighboring tumor cells to initiate cell killing Concluding the longitudinal impact of such method on resistance as well as toxicity through such alternative routes of…Read more

day: Conference Day One